Directory

Thrombosis / thromboembolism

The Ottawa Hospital’s Thrombosis Program is a centre of excellence in both clinical research and clinical care of thrombosis related illness. We are devoted to generating practice-changing knowledge in the areas of diagnosis, treatment and prevention of deep vein thrombosis and pulmonary embolism (venous thromboembolism).

Thrombosis Program’s Mission

The primary mission of the program is to energetically better the lives of patients with venous thromboembolic disease. This is accomplished through:

  • the design, conduct and dissemination of practice-changing clinical research
  • education of the next generation of leaders in Adult Thrombosis Medicine (expert clinicians, educators and researchers)
  • the delivery of quality cost-effective care to patients with venous thromboembolic disease in the Ottawa region

Thrombosis Program’s Vision 

It is our vision to be world leaders in developing practice-changing knowledge generation in the areas of venous thromboembolism. Our group has a strongly established presence in the development of patient-oriented research on diagnostic algorithms for suspected deep vein thrombosis and suspected pulmonary embolism and cancer-associated thrombosis. We are growing an important research program on the management of anticoagulant-related bleeding complications. We also seek to be leaders in the next generation of experts in venous thromboembolism through our Area of Focussed Competency (AFC) Adult Thrombosis Medicine Fellowship (Clinical and Research Fellowship Programs). Finally, and importantly, we seek to deliver cost-effective quality care to patients with venous thromboembolism in the Ottawa region through the development of an Ottawa Regional Clinical Thrombosis Program with arms of the program including thromboembolism management, peri-operative anticoagulation and oral anticoagulation management.


Labs and Groups

These research teams may include multiple scientists, investigators, staff and trainees all working towards a common goal, or they can represent a single scientist and their team.

Research Group
Burger Lab
Our laboratory seeks to apply our expertise in the area of extracellular vesicle biology to explore mechanisms involved in the pathogenesis of chro...
Gray line-style icon of a microscope.
Research Group
HERO Group (Dr. Thavorn)
Lead by Dr. Kednapa Thavorn, the HERO group's primary fields of research are health economics, health technology assessment and health equity.
Philip Berardi
Clinician Investigator

Philip Berardi

Clinician Investigator, Cancer Research
Dylan Burger
Scientist

Dylan Burger

Senior Scientist, Inflammation and Chronic Disease
Marc Carrier
Scientist

Marc Carrier

Senior Scientist, Inflammation and Chronic Disease
Lana Castellucci
Scientist

Lana Castellucci

Scientist, Inflammation and Chronic Disease
Aurelien Delluc
Scientist

Aurelien Delluc

Scientist, Inflammation and Chronic Disease
Placeholder image for a user profile.
Scientist

Lisa Duffett

Associate Scientist, Inflammation and Chronic Disease
Gregoire Le Gal
Scientist

Gregoire Le Gal

Senior Scientist, Inflammation and Chronic Disease
Placeholder image for a user profile.
Affiliate

Marc Rodger

Senior Scientist Affiliate, Acute Care Research
Marlise Santos
Clinician Investigator

Marlise Santos

Clinician Investigator, Neuroscience
Headshot
Scientist

Joseph Shaw

Associate Scientist, Inflammation and Chronic Disease
Manish Sood
Scientist

Manish Sood

Senior Scientist, Inflammation and Chronic Disease
Kednapa Thavorn
Scientist

Kednapa Thavorn

Senior Scientist, Methodological and Implementation Research
Tzu-Fei Wang
Scientist

Tzu-Fei Wang

Scientist, Inflammation and Chronic Disease
Placeholder image for a user profile.
Clinician Investigator

Xiang Wang

Clinician Investigator, Inflammation and Chronic Disease
Philip Wells
Scientist

Philip Wells

Senior Scientist, Inflammation and Chronic Disease
Yan Xu
Scientist

Yan Xu

Associate Scientist, Inflammation and Chronic Disease

Clinical Trials

The following list of clinical trials at The Ottawa Hospital is pulled from ClinicalTrials.gov, which is hosted by the U.S. National Library of Medicine and only available in English. If you find a clinical trial that interests you, you can bring the information to the next appointment with your care team and ask if you are eligible for the study. If so, they may be able to refer you to the study team. If you email the study team directly, we can guarantee a response. Learn more about participating in research and clinical trials.

Publications

The following research publications from The Ottawa Hospital are pulled from PubMed, with publication date of 2020 or later. Note that PubMed is hosted by the U.S. National Library of Medicine and is only available in English.

A Multicenter Prospective Cohort Study on the Use of Weight-Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism-The WAVe Study.

2026-01-01 Go to publication

Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial.

2025-12-06 Go to publication

Safety and efficiency of D-dimer testing in combination with clinical decision rules to exclude pulmonary embolism in patients with cancer: individual patient data meta-analysis.

2025-12-05 Go to publication

Implementation failure: thromboprophylaxis in ambulatory patients with cancer.

2025-12-05 Go to publication

Major Bleeding With Apixaban vs Aspirin: A Subanalysis of the ARTESiA Randomized Clinical Trial.

2025-12-01 Go to publication
View More on PubMed